Koyfin Home > Directory > Health Care > Akebia Therapeutics > Total Debt / Equity

Akebia Therapeutics Total Debt / Equity Chart (AKBA)

Akebia Therapeutics annual/quarterly Total Debt / Equity from 2014 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Akebia Therapeutics Total Debt / Equity for the quarter ending June 06, 2020 was $29m a 74.92% increase of 22m year over year
  • Akebia Therapeutics Total Debt / Equity for the last 12 months ending June 06, 2020 was $29m a 74.92% increase of 22m year over year
  • Akebia Therapeutics Annual Total Debt / Equity for 2019 was $27m a 91.40% increase of 25m from 2018
  • Akebia Therapeutics Annual Total Debt / Equity for 2018 was $2m
Other Ratios Metrics:
  • Akebia Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $2m a 99.29% increase of 2m year over year
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
View Chart On Koyfin

Quarterly AKBA Total Debt / Equity Data

06/2020$29m
03/2020$27m
12/2019$27m
09/2019$7m
06/2019$7m
03/2019$6m
12/2018$2m
09/2017$0m
06/2017$0m
03/2017$0m

Annual AKBA Total Debt / Equity Data

2019$27m
2018$2m